R66L (p.Arg66Leu) variant of NCF2 (Neutrophil cytosol factor 2)

R66L (p.Arg66Leu) in NCF2 (Neutrophil cytosol factor 2) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.21 / 1. The record also includes population frequency data, experimental measurements, and structural context.

R66L (p.Arg66Leu) variant details